RNU6-988P

Across TCGA pan-cancer cohorts, RNU6-988P RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated RNU6-988P data layer.

The strongest signal is observed in mesothelioma (MESO), where higher RNU6-988P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-988P expression acts as an unfavorable survival marker, although some lineages such as BLCA and CESC show a favorable association.

MESO, LIHC, and BLCA are the cancer types where RNU6-988P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	IV	0.137	0.669	<.001	57	view →
LIHC	DFS	Tertile	All	0.216	0.581	<.001	42	view →
BLCA	DFS	Tertile	IV	0.743	0.278	.016	27	view →
SKCM	DFS	Tertile	IV	0.036	0.433	<.001	27	view →
CESC	OS	Tertile	All	0.882	0.757	.009	26	view →
KIRC	DFS	Quartile	IV	0.359	0.535	.021	14	view →
ESCA	OS	Median	III,IV	0.629	0.307	.004	12	view →
STAD	DFS	Median	III,IV	0.659	0.489	.020	8	view →
OV	DFS	Quartile	IV	0.314	0.499	.036	6	view →
KIRP	DFS	Tertile	All	1.000	0.898	.020	3	view →
LAML	DFS	Median	All	0.689	0.470	.044	2	view →
LUAD	OS	Quartile	II,III,IV	0.632	0.775	.045	1	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

RNU6-988P–MESO (OS)

Open the MESO breakdown →